These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20940181)

  • 21. In vivo selection of aac(6')-Ib-cr and mutations in the gyrA gene in a clinical qnrS1-positive Salmonella enterica serovar Typhimurium DT104B strain recovered after fluoroquinolone treatment.
    de Toro M; Rojo-Bezares B; Vinué L; Undabeitia E; Torres C; Sáenz Y
    J Antimicrob Chemother; 2010 Sep; 65(9):1945-9. PubMed ID: 20639314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates.
    Sorlozano A; Gutierrez J; Jimenez A; de Dios Luna J; Martínez JL
    J Clin Microbiol; 2007 Aug; 45(8):2740-2. PubMed ID: 17567787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
    Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
    Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
    Yamane K; Wachino J; Suzuki S; Kimura K; Shibata N; Kato H; Shibayama K; Konda T; Arakawa Y
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3354-60. PubMed ID: 17548499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of qnr determinants among extended-spectrum beta-lactamase-positive Enterobacteriaceae clinical isolates in southern Stockholm, Sweden.
    Fang H; Huang H; Shi Y; Hedin G; Nord CE; Ullberg M
    Int J Antimicrob Agents; 2009 Sep; 34(3):268-70. PubMed ID: 19409763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates.
    Ríos E; López MC; Rodríguez-Avial I; Pena I; Picazo JJ
    Microb Drug Resist; 2015 Oct; 21(5):512-5. PubMed ID: 25945693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased prevalence of plasmid-mediated quinolone resistance determinants in chicken Escherichia coli isolates from 2001 to 2007.
    Huang SY; Dai L; Xia LN; Du XD; Qi YH; Liu HB; Wu CM; Shen JZ
    Foodborne Pathog Dis; 2009 Dec; 6(10):1203-9. PubMed ID: 19735206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional Characterization of the DNA Gyrases in Fluoroquinolone-Resistant Mutants of Francisella novicida.
    Caspar Y; Siebert C; Sutera V; Villers C; Aubry A; Mayer C; Maurin M; Renesto P
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid and sensitive detection of fluoroquinolone-resistant Escherichia coli from urine samples using a genotyping DNA microarray.
    Yu X; Susa M; Weile J; Knabbe C; Schmid RD; Bachmann TT
    Int J Med Microbiol; 2007 Oct; 297(6):417-29. PubMed ID: 17482874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens.
    Li Q; Bi X; Diao Y; Deng X
    Am J Vet Res; 2007 Aug; 68(8):812-5. PubMed ID: 17669019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the contribution of gyrA mutation and efflux pumps to fluoroquinolone and multidrug resistance in pathogenic Escherichia coli isolates from dogs and cats.
    Shaheen BW; Boothe DM; Oyarzabal OA; Wang C; Johnson CM
    Am J Vet Res; 2011 Jan; 72(1):25-32. PubMed ID: 21194332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates.
    Higgins PG; Stubbings W; Wisplinghoff H; Seifert H
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1613-5. PubMed ID: 20100879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of fluoroquinolone resistance mechanisms and their correlation with the degree of resistance to clinically used fluoroquinolones among Escherichia coli isolates.
    Chang TM; Lu PL; Li HH; Chang CY; Chen TC; Chang LL
    J Chemother; 2007 Oct; 19(5):488-94. PubMed ID: 18073146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interplay in the selection of fluoroquinolone resistance and bacterial fitness.
    Marcusson LL; Frimodt-Møller N; Hughes D
    PLoS Pathog; 2009 Aug; 5(8):e1000541. PubMed ID: 19662169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
    J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms of fluoroquinolone resistance.
    Chen FJ; Lo HJ
    J Microbiol Immunol Infect; 2003 Mar; 36(1):1-9. PubMed ID: 12741725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.
    Hooper DC; Jacoby GA
    Cold Spring Harb Perspect Med; 2016 Sep; 6(9):. PubMed ID: 27449972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolated from diseased animals in Taiwan.
    Yeh JC; Lo DY; Chang SK; Chou CC; Kuo HC
    J Vet Med Sci; 2017 Apr; 79(4):730-735. PubMed ID: 28250288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.